Center for Molecular Biology of Oral Diseases, College of Dentistry, University of Illinois at Chicago, 801 S. Paulina Street, Room 530C, Chicago, IL 60612, USA.
Hum Genet. 2011 Feb;129(2):189-97. doi: 10.1007/s00439-010-0915-3. Epub 2010 Nov 16.
MicroRNA deregulation is a critical event in tumor initiation and progression. The down-regulation of microRNA-138 has been frequently observed in various cancers, including tongue squamous cell carcinoma (TSCC). Our previous studies suggest that deregulation of miR-138 is associated with the enhanced proliferation and invasion in TSCC cells. Here, we seek to identify the targets of miR-138 in TSCC, and explore their functional relevance in tumorigenesis. Our genome-wide expression profiling experiments identified a panel of 194 unique transcripts that were significantly down-regulated in TSCC cells transfected with miR-138. A comprehensive screening using six different sequence-based microRNA target prediction algorithms revealed that 51 out of these 194 down-regulated transcripts are potential direct targets for miR-138. These targets include: chloride channel, nucleotide-sensitive, 1A (CLNS1A), G protein alpha inhibiting activity polypeptide 2 (GNAI2), solute carrier family 20, member 1 (SLC20A1), eukaryotic translation initiation factor 4E binding protein 1 (EIF4EBP1), and Rho-related GTP-binding protein C (RhoC). GNAI2 is a known proto-oncogene that is involved in the initiation and progression of several different types of tumors. Direct targeting of miR-138 to two candidate binding sequences located in the 3'-untranslated region of GNAI2 mRNA was confirmed using luciferase reporter gene assays. Knockdown of miR-138 in TSCC cells enhanced the expression of GNAI2 at both mRNA and protein levels. In contrast, ectopic transfection of miR-138 reduced the expression of GNAI2, which, in consequence, led to reduced proliferation, cell cycle arrest and apoptosis. In summary, we identified a number of high-confident miR-138 target genes, including proto-oncogene GNAI2, which may play an important role in TSCC initiation and progression.
microRNA 失调是肿瘤发生和发展的关键事件。miR-138 的下调在各种癌症中经常被观察到,包括舌鳞状细胞癌 (TSCC)。我们之前的研究表明,miR-138 的失调与 TSCC 细胞的增殖和侵袭增强有关。在这里,我们试图确定 miR-138 在 TSCC 中的靶标,并探讨它们在肿瘤发生中的功能相关性。我们的全基因组表达谱实验鉴定了一组 194 个独特的转录本,这些转录本在转染 miR-138 的 TSCC 细胞中显著下调。使用六种不同的基于序列的 microRNA 靶标预测算法进行全面筛选,发现这 194 个下调转录本中有 51 个是 miR-138 的潜在直接靶标。这些靶标包括:氯离子通道、核苷酸敏感、1A(CLNS1A)、G 蛋白α抑制活性多肽 2(GNAI2)、溶质载体家族 20 成员 1(SLC20A1)、真核翻译起始因子 4E 结合蛋白 1(EIF4EBP1)和 Rho 相关 GTP 结合蛋白 C(RhoC)。GNAI2 是一种已知的原癌基因,参与多种类型肿瘤的发生和发展。使用荧光素酶报告基因检测证实了 miR-138 直接靶向位于 GNAI2 mRNA 3'-非翻译区的两个候选结合序列。在 TSCC 细胞中敲低 miR-138 会增强 GNAI2 的 mRNA 和蛋白水平表达。相反,外源性转染 miR-138 会降低 GNAI2 的表达,从而导致增殖减少、细胞周期停滞和凋亡。总之,我们鉴定了一些高置信度的 miR-138 靶基因,包括原癌基因 GNAI2,它可能在 TSCC 的发生和发展中起重要作用。